Inhibition of the ERK5 protein kinase reduces the proliferation and survival of endometrial cancer cells, and potentiates standard chemotherapy
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the third...
Read moreFinal data of Phase II ALICE trial in unfit AML patients treated with iadademstat and azacitidine
Read moreUsing a mouse model, the research team characterized the protein profile of small vesicles secreted by liver cells, where the latent form of the parasite hides
Read moreGalecto, Inc., a clinical-stage biotechnology company and a world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer, announced it will discuss topline d...
Read moreKala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today reported...
Read moreOryzon Genomics S. A., announced today that the FDA has approved the Investigational New Drug (IND) application to initiate a Phase II collaborative study with iadademstat in patients with relapsed/re...
Read moreThe trial will evaluate the efficacy and safety of belzupacap sarotalocan (bel-sar) with suprachoroidal administration, for the first-line treatment of early-stage choroidal melanoma (CM).
Read more3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegene...
Read moreLa polipíldora merecedora del premio ABC Salud ha presentado resultados de un estudio que aporta evidencia de una reducción del 33 por ciento en mortalidad por causa cardiovascular.
Read moreLecanemab reduce los marcadores de amiloide y ha conseguido ralentizar en un 27% el deterioro cognitivo en pacientes en fases iniciales del Alzheimer. Se trata pues del primer fármaco que conseguirí...
Read more